Alzheimer's beyond amyloidosis: WMHs matter, too, study finds

02/18/2013 | MolecularImaging.net

Amyloid accumulation may play a role in the development of Alzheimer’s disease, but it may not be enough to diagnose the disease, according to a study published in JAMA Neurology. Small-vessel cerebrovascular disease, which manifests as white matter hyperintensities, may also play a role in the development of the disease, the study said, and the combined factors appear to be involved in manifestation of disease. The researchers used C-11-PIB-PET imaging to detect amyloid buildup and structural MRI to measure WMH. "The findings suggest a role of small-vessel cerebrovascular disease in the clinical presentation of AD and point to the importance of incorporating WMH into the formulation of pathogenic models of the disease," the researchers wrote.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC